Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John P Moore

Showing results (171-180 of 320) with videos related to

Pageof 32
Sort By:
AIDS Research and Human Retroviruses|April 12, 2003
Entry inhibitors SCH-C, RANTES, and T-20 block HIV type 1 replication in multiple cell typesThomas J Ketas, Per Johan Klasse, Catherine Spenlehauer, et al.
Journal of Virology|July 5, 2005
Evaluating the immunogenicity of a disulfide-stabilized, cleaved, trimeric form of the envelope glycoprotein complex of human immunodeficiency virus type 1Simon Beddows, Norbert Schülke, Marc Kirschner, et al.
Retrovirology|September 28, 2015
Presenting native-like HIV-1 envelope trimers on ferritin nanoparticles improves their immunogenicityKwinten Sliepen, Gabriel Ozorowski, Judith A Burger, et al.
Virology|June 4, 2005
The impact of envelope glycoprotein cleavage on the antigenicity, infectivity, and neutralization sensitivity of Env-pseudotyped human immunodeficiency virus type 1 particlesCarolina Herrera, Per Johan Klasse, Elizabeth Michael, et al.
Journal of Virology|January 29, 2003
Human immunodeficiency virus type 1 attachment, coreceptor, and fusion inhibitors are active against both direct and trans infection of primary cellsThomas J Ketas, Ines Frank, Per Johan Klasse, et al.
Virology|May 5, 2009
Enzymatic removal of mannose moieties can increase the immune response to HIV-1 gp120 in vivoKaustuv Banerjee, Sofija Andjelic, Per Johan Klasse, et al.
Journal of Virology|March 8, 2013
Use of G-protein-coupled and -uncoupled CCR5 receptors by CCR5 inhibitor-resistant and -sensitive human immunodeficiency virus type 1 variantsReem Berro, Anila Yasmeen, Ravinder Abrol, et al.
Journal of Virology|June 27, 2014
Structure of 2G12 Fab2 in complex with soluble and fully glycosylated HIV-1 Env by negative-stain single-particle electron microscopyCharles D Murin, Jean-Philippe Julien, Devin Sok, et al.
The Journal of Biological Chemistry|April 26, 2011
A chimeric HIV-1 envelope glycoprotein trimer with an embedded granulocyte-macrophage colony-stimulating factor (GM-CSF) domain induces enhanced antibody and T cell responsesThijs van Montfort, Mark Melchers, Gözde Isik, et al.
Plos One|July 11, 2013
Comparative Immunogenicity of Evolved V1V2-Deleted HIV-1 Envelope Glycoprotein TrimersIlja Bontjer, Mark Melchers, Tommy Tong, et al.
Pageof 32

Showing results (171-180 of 320) with videos related to

Sort By:
Pageof 32
AIDS Research and Human Retroviruses|April 12, 2003
Entry inhibitors SCH-C, RANTES, and T-20 block HIV type 1 replication in multiple cell typesThomas J Ketas, Per Johan Klasse, Catherine Spenlehauer, et al.
Journal of Virology|July 5, 2005
Evaluating the immunogenicity of a disulfide-stabilized, cleaved, trimeric form of the envelope glycoprotein complex of human immunodeficiency virus type 1Simon Beddows, Norbert Schülke, Marc Kirschner, et al.
Retrovirology|September 28, 2015
Presenting native-like HIV-1 envelope trimers on ferritin nanoparticles improves their immunogenicityKwinten Sliepen, Gabriel Ozorowski, Judith A Burger, et al.
Virology|June 4, 2005
The impact of envelope glycoprotein cleavage on the antigenicity, infectivity, and neutralization sensitivity of Env-pseudotyped human immunodeficiency virus type 1 particlesCarolina Herrera, Per Johan Klasse, Elizabeth Michael, et al.
Journal of Virology|January 29, 2003
Human immunodeficiency virus type 1 attachment, coreceptor, and fusion inhibitors are active against both direct and trans infection of primary cellsThomas J Ketas, Ines Frank, Per Johan Klasse, et al.
Virology|May 5, 2009
Enzymatic removal of mannose moieties can increase the immune response to HIV-1 gp120 in vivoKaustuv Banerjee, Sofija Andjelic, Per Johan Klasse, et al.
Journal of Virology|March 8, 2013
Use of G-protein-coupled and -uncoupled CCR5 receptors by CCR5 inhibitor-resistant and -sensitive human immunodeficiency virus type 1 variantsReem Berro, Anila Yasmeen, Ravinder Abrol, et al.
Journal of Virology|June 27, 2014
Structure of 2G12 Fab2 in complex with soluble and fully glycosylated HIV-1 Env by negative-stain single-particle electron microscopyCharles D Murin, Jean-Philippe Julien, Devin Sok, et al.
The Journal of Biological Chemistry|April 26, 2011
A chimeric HIV-1 envelope glycoprotein trimer with an embedded granulocyte-macrophage colony-stimulating factor (GM-CSF) domain induces enhanced antibody and T cell responsesThijs van Montfort, Mark Melchers, Gözde Isik, et al.
Plos One|July 11, 2013
Comparative Immunogenicity of Evolved V1V2-Deleted HIV-1 Envelope Glycoprotein TrimersIlja Bontjer, Mark Melchers, Tommy Tong, et al.
Pageof 32